Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Lecocq

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Biochemical and Biophysical Research Communications|August 15, 1985
Evaluation of recombinant DNA-directed E.coli produced alpha 1-antitrypsin as an anti-neutrophil elastase for potential use as replacement therapy of alpha 1-antitrypsin deficiencyS D Straus, G A Fells, M D Wewers, et al.
Nature|March 12, 1987
Molecular cloning of a protective antigen of schistosomesJ M Balloul, P Sondermeyer, D Dreyer, et al.
The American Journal of Physiology|March 1, 1993
Low-conductance chloride channels in IEC-6 and CF nasal cells expressing CFTRJ Bijman, W Dalemans, M Kansen, et al.
Parasite Immunology|August 1, 1994
Vaccination of goats against the trematode Schistosoma bovis with a recombinant homologous schistosome-derived glutathione S-transferaseD Boulanger, F Trottein, F Mauny, et al.
Nature|July 18, 1985
Active gamma-carboxylated human factor IX expressed using recombinant DNA techniquesH de la Salle, W Altenburger, R Elkaim, et al.
European Journal of Immunology|December 1, 1988
HIV-specific T lymphocyte immunity in mice immunized with a recombinant vaccinia virusF Michel, A Hoffenbach, P Langlade-Demoyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1984
High-level production of biologically active human alpha 1-antitrypsin in Escherichia coliM Courtney, A Buchwalder, L H Tessier, et al.
Nature|December 19, 1991
Large-scale eradication of rabies using recombinant vaccinia-rabies vaccineB Brochier, M P Kieny, F Costy, et al.
Journal of Wildlife Diseases|October 1, 1989
Use of recombinant vaccinia-rabies glycoprotein virus for oral vaccination of wildlife against rabies: innocuity to several non-target bait consuming speciesB Brochier, J Blancou, I Thomas, et al.
The Journal of Experimental Medicine|September 1, 1990
Immunological crossreactivity between the human immunodeficiency virus type 1 virion infectivity factor and a 170-kD surface antigen of Schistosoma mansoniJ Khalife, J M Grzych, R Pierce, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Biochemical and Biophysical Research Communications|August 15, 1985
Evaluation of recombinant DNA-directed E.coli produced alpha 1-antitrypsin as an anti-neutrophil elastase for potential use as replacement therapy of alpha 1-antitrypsin deficiencyS D Straus, G A Fells, M D Wewers, et al.
Nature|March 12, 1987
Molecular cloning of a protective antigen of schistosomesJ M Balloul, P Sondermeyer, D Dreyer, et al.
The American Journal of Physiology|March 1, 1993
Low-conductance chloride channels in IEC-6 and CF nasal cells expressing CFTRJ Bijman, W Dalemans, M Kansen, et al.
Parasite Immunology|August 1, 1994
Vaccination of goats against the trematode Schistosoma bovis with a recombinant homologous schistosome-derived glutathione S-transferaseD Boulanger, F Trottein, F Mauny, et al.
Nature|July 18, 1985
Active gamma-carboxylated human factor IX expressed using recombinant DNA techniquesH de la Salle, W Altenburger, R Elkaim, et al.
European Journal of Immunology|December 1, 1988
HIV-specific T lymphocyte immunity in mice immunized with a recombinant vaccinia virusF Michel, A Hoffenbach, P Langlade-Demoyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1984
High-level production of biologically active human alpha 1-antitrypsin in Escherichia coliM Courtney, A Buchwalder, L H Tessier, et al.
Nature|December 19, 1991
Large-scale eradication of rabies using recombinant vaccinia-rabies vaccineB Brochier, M P Kieny, F Costy, et al.
Journal of Wildlife Diseases|October 1, 1989
Use of recombinant vaccinia-rabies glycoprotein virus for oral vaccination of wildlife against rabies: innocuity to several non-target bait consuming speciesB Brochier, J Blancou, I Thomas, et al.
The Journal of Experimental Medicine|September 1, 1990
Immunological crossreactivity between the human immunodeficiency virus type 1 virion infectivity factor and a 170-kD surface antigen of Schistosoma mansoniJ Khalife, J M Grzych, R Pierce, et al.
Pageof 8